PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW146150View Pathway |
drug action
Protirelin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:31 Last Updated: October 07, 2023 at 17:31 |
PW064773View Pathway |
signaling
Protocadherin Fat 1Homo sapiens
|
Creator: Guest: Anonymous Created On: June 20, 2018 at 03:13 Last Updated: June 20, 2018 at 03:13 |
PW145815View Pathway |
drug action
Protokylol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:44 Last Updated: October 07, 2023 at 16:44 |
PW144470View Pathway |
drug action
Protriptyline Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:42 Last Updated: October 07, 2023 at 13:42 |
PW176124View Pathway |
Protriptyline Predicted Metabolism Pathway newHomo sapiens
Metabolites of Protriptyline are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:08 Last Updated: November 29, 2023 at 14:08 |
PW132492View Pathway |
Proxibarbal Drug MetabolismHomo sapiens
Proxibarbal is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Proxibarbal passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:04 Last Updated: September 21, 2023 at 22:04 |
PW146622View Pathway |
drug action
Proxibarbal Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:39 Last Updated: October 07, 2023 at 18:39 |
PW000909View Pathway |
PRPP BiosynthesisEscherichia coli
The biosynthesis of phosphoribosyl pyrophosphate begins as a product of the pentose phosphate and D-ribose 5-phosphate interaction. When catalyzed with a phosphopentomutase, the product is a ribose 1-phosphate. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. Ribose 1,5-biphosphate is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. Phosphoribosyl pyrophosphate will then participate in the purine nucleotides de novo biosynthesis pathway. Alternatively pentose phosphate and D-ribose 5-phosphate's interaction can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate which will again participate in the purine nucleotides de novo biosynthesis pathway.
|
Creator: miguel ramirez Created On: May 29, 2015 at 13:29 Last Updated: May 29, 2015 at 13:29 |
PW122417View Pathway |
PRPP BiosynthesisSaccharomyces cerevisiae
The biosynthesis of phosphoribosyl pyrophosphate begins with a product of the pentose phosphate, D-ribose 5-phosphate interact with a phosphopentomutase resulting in a Ribose 1-phosphate or it can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate. The latter compound is then involved in the purine nucleotides de novo biosynthesis pathway. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. The latter compound is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. The latter compound is then involved in the purine nucleotides de novo biosynthesis pathway.
|
Creator: Debra Lipton Created On: March 27, 2019 at 15:16 Last Updated: March 27, 2019 at 15:16 |
PW128663View Pathway |
drug action
Prucalopride Action PathwayHomo sapiens
Prucalopride acts as a selective stimulator of the 5-HT4 receptors while having no interaction with hERG channel or 5-HT1 receptors which reduces significantly the cardiovascular risk found in other similar drugs. 5-HT4 receptors can be found throughout the gastrointestinal tract primarily in smooth muscle cells, enterochromaffin cells, and myenteric plexus. Its activation produces the release of acetylcholine which is the major excitatory neurotransmitter in the GI tract. Hence, prucalopride stimulates motility by interacting specifically with 5-HT4 receptors in the GI tract which causes a release of acetylcholine and further contraction of the muscle layer of the colon and relaxation of the circular muscle layer leading to the propulsion of luminal content. Prucalopride is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
|
Creator: Omolola Created On: September 08, 2023 at 15:12 Last Updated: September 08, 2023 at 15:12 |